About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [176 citations: 1–100 of 158 articles]

Articles published in Schizophrenia Research and Treatment have been cited 176 times. The following is a list of the 158 articles that have cited the articles published in Schizophrenia Research and Treatment.

  • J. Long, G. Huang, W. Liang, B. Liang, Q. Chen, J. Xie, J. Jiang, and L. Su, “The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys,” Acta Psychiatrica Scandinavica, 2014. View at Publisher · View at Google Scholar
  • Jin Dang, Jiangtao Zhang, Zhongwei Guo, Weihong Lu, Jun Cai, Zhongying Shi, and Chen Zhang, “A Pilot Study of iPad-assisted Cognitive Training for Schizophrenia,” Archives of Psychiatric Nursing, 2014. View at Publisher · View at Google Scholar
  • Hatice Durmaz, and Ayşe Okanlı, “Investigation of the Effect of Self-Efficacy Levels of Caregiver Family Members of the Individuals With Schizophrenia on Burden of Care,” Archives of Psychiatric Nursing, 2014. View at Publisher · View at Google Scholar
  • Zoltán Sarnyai, Cassandra Jashar, and Berend Olivier, “Modeling combined schizophrenia-related behavioral and metabolic phenotypes in rodents,” Behavioural Brain Research, 2014. View at Publisher · View at Google Scholar
  • Heline Mirzakhanian, Fiza Singh, and Kristin S. Cadenhead, “Biomarkers in psychosis: an approach to early identification and individualized treatment,” Biomarkers in Medicine, vol. 8, no. 1, pp. 51–57, 2014. View at Publisher · View at Google Scholar
  • Ajeet B Singh, Andrew A Nierenberg, Lakshmi N Yatham, and Michael Berk, “Atypical antipsychotic agents; Peas in a pod or chalk and cheese?,” BMC Medicine, vol. 12, no. 1, pp. 126, 2014. View at Publisher · View at Google Scholar
  • Bess Y. H. Lam, Adrian Raine, and Tatia M. C. Lee, “The relationship between neurocognition and symptomatology in people with schizophrenia: social cognition as the mediator,” Bmc Psychiatry, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Carmen Miralles, Yolanda Alonso, Begona Verge, Sonia Seto, Ana M. Gaviria, Lorena Moreno, Maria J. Cortes, Alfonso Gutierrez-Zotes, Elisabet Vilella, and Lourdes Martorell, “Personality dimensions of schizophrenia patients compared to control subjects by gender and the relationship with illness severity,” Bmc Psychiatry, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Xiao Chang, Hui Shen, Lubin Wang, Zhening Liu, Wei Xin, Dewen Hu, and Danmin Miao, “Altered default mode and fronto-parietal network subsystems in patients with schizophrenia and their unaffected siblings,” Brain Research, vol. 1562, pp. 87–99, 2014. View at Publisher · View at Google Scholar
  • S. Jauhar, P. J. McKenna, J. Radua, E. Fung, R. Salvador, and K. R. Laws, “Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias,” British Journal of Psychiatry, vol. 204, no. 1, pp. 20–29, 2014. View at Publisher · View at Google Scholar
  • Christine Lycke Brandt, Tom Eichele, Ingrid Melle, Kjetil Sundet, Andres Server, Ingrid Agartz, Kenneth Hugdahl, Jimmy Jensen, and Ole A. Andreassen, “Working memory networks and activation patterns in schizophrenia and bipolar disorder: comparison with healthy controls,” British Journal of Psychiatry, vol. 204, no. 4, pp. 290–298, 2014. View at Publisher · View at Google Scholar
  • Steffen Moritz, Christina Andreou, Brooke C. Schneider, Charlotte E. Wittekind, Mahesh Menon, Ryan P. Balzan, and Todd S. Woodward, “Sowing the seeds of doubt: a narrative review on metacognitive training in schizophrenia,” Clinical Psychology Review, 2014. View at Publisher · View at Google Scholar
  • Tania M. Lincoln, Carolin Möbius, Martin T. Huber, Matthias Nagel, and Steffen Moritz, “Frequency and correlates of maladaptive responses to paranoid thoughts in patients with psychosis compared to a population sample,” Cognitive Neuropsychiatry, pp. 1–18, 2014. View at Publisher · View at Google Scholar
  • Tania M. Lincoln, Jonas Stahnke, and Steffen Moritz, “The Short-Term Impact of a Paranoid Explanation on Self-esteem: An Experimental Study,” Cognitive Therapy and Research, 2014. View at Publisher · View at Google Scholar
  • Barbara Remberk, Anna Katarzyna Bażyńska, Anna Krempa-Kowalewska, and Filip Rybakowski, “Adolescent insanity revisited: Course and outcome in early-onset schizophrenia spectrum psychoses in an 8-year follow-up study,” Comprehensive Psychiatry, vol. 55, no. 5, pp. 1174–1181, 2014. View at Publisher · View at Google Scholar
  • Marie-Hélène Lafeuille, Jason Dean, Valerie Carter, Mei Sheng Duh, John Fastenau, Riad Dirani, and Patrick Lefebvre, “Systematic Review of Long-Acting Injectables versus Oral Atypical Antipsychotics on Hospitalization in Schizophrenia,” Current Medical Research and Opinion, pp. 1–43, 2014. View at Publisher · View at Google Scholar
  • Dolores Malaspina, Julie Walsh-Messinger, Wolfgang Gaebel, Lianne Morris Smith, Alyson Gorun, Vasthie Prudent, Daniel Antonius, and Fabien Tremeau, “Negative symptoms, past and present: A historical perspective and moving to DSM-5,” European Neuropsychopharmacology, vol. 24, no. 5, pp. 710–724, 2014. View at Publisher · View at Google Scholar
  • Elena Huerta-Ramos, Raquel Iniesta, Susana Ochoa, Jesus Cobo, Eva Miquel, Mercedes Roca, Antoni Serrano-Blanco, Fernando Teba, and Judith Usall, “Effects of raloxifene on cognition in postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial,” European Neuropsychopharmacology, vol. 24, no. 2, pp. 223–231, 2014. View at Publisher · View at Google Scholar
  • John D. Salamone, Ivan Koychev, Mercè Correa, and Philip McGuire, “Neurobiological basis of motivational deficits in psychopathology,” European Neuropsychopharmacology, 2014. View at Publisher · View at Google Scholar
  • Marc De Hert, Johan Detraux, and Joseph Peuskens, “Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review,” Expert Opinion on Drug Safety, pp. 1–20, 2014. View at Publisher · View at Google Scholar
  • Larry Alphs, Cynthia A. Bossie, Dong-Jing Fu, Yi-Wen Ma, and Jennifer Kern Sliwa, “Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia,” Expert Opinion on Pharmacotherapy, vol. 15, no. 7, pp. 1029–1042, 2014. View at Publisher · View at Google Scholar
  • W. Woelwer, A. Lowe, and N. Frommann, “Training of Social-Cognitive Functions - New Approaches towards the Avoidance of Psychosocial Disabilities in Schizophrenia,” Fortschritte der Neurologie Psychiatrie, vol. 82, no. 4, pp. 203–209, 2014. View at Publisher · View at Google Scholar
  • Myrthel Dogge, Dennis Hofman, Maria Boersma, H. Chris Dijkerman, and Henk Aarts, “Cortical information flow during inferences of agency,” Frontiers in Human Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Julie Champagne, Adrianna Mendrek, Martine Germain, Pascal Hot, and Marc E. Lavoie, “Event-related brain potentials to emotional images and gonadal steroid hormone levels in patients with schizophrenia and paired controls,” Frontiers in Psychology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Thibaut Dondaine, Gabriel Robert, Julie Péron, Didier Grandjean, Marc Vérin, Dominique Drapier, and Bruno Millet, “Biases in facial and vocal emotion recognition in chronic schizophrenia,” Frontiers in Psychology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Richard Uwakwe, and Alex Otakpor, “Public Mental Health – Using the Mental Health Gap Action Program to Put all Hands to the Pumps,” Frontiers in Public Health, vol. 2, 2014. View at Publisher · View at Google Scholar
  • V. Haroutunian, P. Katsel, P. Roussos, K. L. Davis, L. L. Altshuler, and G. Bartzokis, “Myelination, oligodendrocytes, and serious mental illness,” Glia, 2014. View at Publisher · View at Google Scholar
  • Carol Curtin, Mirjana Jojic, and Linda G. Bandini, “Obesity in Children with Autism Spectrum Disorder,” Harvard Review of Psychiatry, vol. 22, no. 2, pp. 93–103, 2014. View at Publisher · View at Google Scholar
  • Dong-Jing Fu, Cynthia A. Bossie, Jennifer K. Sliwa, Yi-Wen Ma, and Larry Alphs, “Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison,” International Clinical Psychopharmacology, vol. 29, no. 1, pp. 45–55, 2014. View at Publisher · View at Google Scholar
  • Nam Young Lee, Se Hyun Kim, Seong Jin Cho, Young-Cho Chung, In Kwa Jung, Chang Yoon Kim, Duk Ho Kim, Dong Geun Lee, Yo Han Lee, Weon Jeong Lim, Young Suk Na, Sang Eun Shin, Jong-Min Woo, Jin Sang Yoon, Bo-Hyun Yoon, Yong Min Ahn, and Yong Sik Kim, “A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea,” International Clinical Psychopharmacology, vol. 29, no. 5, pp. 279–287, 2014. View at Publisher · View at Google Scholar
  • Brian Dean, Hans-Juergen Moller, Torgny H. Svensson, Mark A. Geyer, Dan Rujescu, Elizabeth Scarr, and Mark J. Millan, “Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank,” International Journal of Neuropsychopharmacology, vol. 17, no. 1, pp. 137–148, 2014. View at Publisher · View at Google Scholar
  • Pavel Mohr, Mabel Rodriguez, Anna Bravermanova, Tomas Melicher, Zuzana Ceplova, Jan Cermak, and Jan Pecenak, “Social and functional capacity of schizophrenia patients: A cross-sectional study,” International Journal of Social Psychiatry, vol. 60, no. 4, pp. 352–358, 2014. View at Publisher · View at Google Scholar
  • Ridha Joober, “Medium range cognitive impairment (MeRCI) hypothesis for psychosis formation: evidence from epidemiological studies and recent molecular genetic developments,” Journal of Psychiatry & Neuroscience, vol. 39, no. 4, pp. 219–222, 2014. View at Publisher · View at Google Scholar
  • Ana Calvo, Miguel Moreno, Ana Ruiz-Sancho, Marta Rapado-Castro, Carmen Moreno, Teresa Sánchez-Gutiérrez, Celso Arango, and María Mayoral, “Intervention for Adolescents With Early Onset Psychosis and Their Families: A Randomized Controlled Trial,” Journal of the American Academy of Child & Adolescent Psychiatry, 2014. View at Publisher · View at Google Scholar
  • Bojidarka Ivanova, and Michael Spiteller, “Functionalized benzyls as selective κ-OR agonists,” Medicinal Chemistry Research, 2014. View at Publisher · View at Google Scholar
  • Robert Stanton, Brenda Happell, and Peter Reaburn, “The development of a questionnaire to investigate the views of health professionals regarding exercise for the treatment of mental illness,” Mental Health and Physical Activity, 2014. View at Publisher · View at Google Scholar
  • K. Yazdi, J. Rosenleitner, and B. Pischinger, “Letters to the Editor - Combination of two depot antipsychotic drugs,” Nervenarzt, vol. 85, no. 7, pp. 870–871, 2014. View at Publisher · View at Google Scholar
  • N.A. Uranova, O.V. Vikhreva, V.I. Rachmanova, and D.D. Orlovskaya, “Microglial activation in white matter in schizophrenia: Findings from a postmortem electron microscopic morphometric study,” Neurology, Psychiatry and Brain Research, vol. 20, no. 1, pp. 25, 2014. View at Publisher · View at Google Scholar
  • M. Cermolacce, S. Scannella, M. Faugere, J. Vion-Dury, and M. Besson, “"All that glitters is not ... alone". Congruity effects in highly and less predictable sentence contexts,” Neurophysiologie Clinique-Clinical Neurophysiology, vol. 44, no. 2, pp. 189–201, 2014. View at Publisher · View at Google Scholar
  • Nmaculada Ibanez-Casas, Sandra Saldivia, Dinarte Ballester, Pamela Grandon, Berta Moreno-Kuestner, Miguel Xavier, and Manuel Gomez-Beneyto, “Unmet needs in the management of schizophrenia,” Neuropsychiatric Disease and Treatment, vol. 10, pp. 97–110, 2014. View at Publisher · View at Google Scholar
  • Ali Mohammad Pourrahimi, Shahrzad Mazhari, Mohammad Shabani, and Vahid Sheibani, “An evidence for lack of pseudoneglect in patients with schizophrenia: An ERP study,” Neuroscience Letters, vol. 561, pp. 96–100, 2014. View at Publisher · View at Google Scholar
  • Urban Ösby, Eric Olsson, Gunnar Edman, Agneta Hilding, Sven V. Eriksson, and Claes Göran Östenson, “Psychotic disorder is an independent risk factor for increased fasting glucose and waist circumference,” Nordic Journal of Psychiatry, vol. 68, no. 4, pp. 251–258, 2014. View at Publisher · View at Google Scholar
  • Michael De Santis, Bo Pan, Jiamei Lian, Xu-Feng Huang, and Chao Deng, “Different Effects of Bifeprunox, Aripiprazole, and Haloperidol on Body Weight Gain, Food and Water Intake, and Locomotor Activity in Rats,” Pharmacology Biochemistry and Behavior, 2014. View at Publisher · View at Google Scholar
  • S. R. T. Veerman, P. F. J. Schulte, and L. de Haan, “The Glutamate Hypothesis: A Pathogenic Pathway from which Pharmacological interventions have Emerged,” Pharmacopsychiatry, vol. 47, no. 4-5, pp. 121–130, 2014. View at Publisher · View at Google Scholar
  • Nobutaka Ohkubo, Etsuko Matsubara, Jun Yamanouchi, Rie Akazawa, Mamoru Aoto, Yoji Suzuki, Ikuya Sakai, Takaya Abe, Hiroshi Kiyonari, Seiji Matsuda, Masaki Yasukawa, and Noriaki Mitsuda, “Abnormal Behaviors and Developmental Disorder of Hippocampus in Zinc Finger Protein 521 (ZFP521) Mutant Mice,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • Annemarie Fransen, Jouke Janssen, Jim van Os, and Marjan Drukker, “Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis,” Plos One, vol. 9, no. 4, 2014. View at Publisher · View at Google Scholar
  • W. Ross Fulham, Patricia T. Michie, Philip B. Ward, Paul E. Rasser, Juanita Todd, Patrick J. Johnston, Paul M. Thompson, and Ulrich Schall, “Mismatch Negativity in Recent-Onset and Chronic Schizophrenia: A Current Source Density Analysis,” Plos One, vol. 9, no. 6, 2014. View at Publisher · View at Google Scholar
  • Michael Bodnar, Cindy L. Hovington, Lisa Buchy, Ashok K. Malla, Ridha Joober, and Martin Lepage, “Cortical Thinning in Temporo-Parietal Junction (TPJ) in Non-Affective First-Episode of Psychosis Patients with Persistent Negative Symptoms,” Plos One, vol. 9, no. 6, 2014. View at Publisher · View at Google Scholar
  • Qingsheng Zhang, Jiamei Lian, Meng He, Chao Deng, Hongqin Wang, and Xu-Feng Huang, “Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2014. View at Publisher · View at Google Scholar
  • S. Nadalin, J. Giacometti, and A. Buretić-Tomljanović, “PPARα-L162V polymorphism Is not associated with schizophrenia risk in a croatian population,” Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 2014. View at Publisher · View at Google Scholar
  • Kim Donoghue, Gillian A. Doody, Robin M. Murray, Peter B. Jones, Craig Morgan, Paola Dazzan, Jozella Hart, Rodolfo Mazzoncini, and James H. MacCabe, “Cannabis use, gender and age of onset of schizophrenia: Data from the ÆSOP study,” Psychiatry Research, 2014. View at Publisher · View at Google Scholar
  • Steffen Moritz, Anja S. Göritz, Niels Van Quaquebeke, Christina Andreou, David Jungclaussen, and Maarten J. Peters, “Knowledge corruption for visual perception in individuals high on paranoia,” Psychiatry Research, 2014. View at Publisher · View at Google Scholar
  • Christina Andreou, András Treszl, Daniela Roesch-Ely, Ulf Köther, Ruth Veckenstedt, and Steffen Moritz, “Investigation of the role of the jumping-to-conclusions bias for short-term functional outcome in schizophrenia,” Psychiatry Research, 2014. View at Publisher · View at Google Scholar
  • Ponnada A. Narayana, Juan J. Herrera, Kurt H Bockhorst, Emilio Esparza-Coss, Ying Xia, Joel L. Steinberg, and F. Gerard Moeller, “Chronic cocaine administration causes extensive white matter damage in brain: Diffusion tensor imaging and immunohistochemistry studies,” Psychiatry Research: Neuroimaging, 2014. View at Publisher · View at Google Scholar
  • Carol P. Weingarten, and Timothy J. Strauman, “Neuroimaging for psychotherapy research: Current trends,” Psychotherapy Research, pp. 1–29, 2014. View at Publisher · View at Google Scholar
  • Alexandre Gonzalez-Rodriguez, Oriol Molina-Andreu, Victor Navarro, Cristobal Gasto, Rafael Penades, and Rosa Catalan, “Delusional disorder: no gender differences in age at onset, suicidal ideation, or suicidal behavior,” Revista Brasileira de Psiquiatria, vol. 36, no. 2, pp. 119–124, 2014. View at Publisher · View at Google Scholar
  • Christina Andreou, Steffen Moritz, Kristina Veith, Ruth Veckenstedt, and Dieter Naber, “Dopaminergic Modulation of Probabilistic Reasoning and Overconfidence in Errors: A Double-Blind Study,” Schizophrenia Bulletin, vol. 40, no. 3, pp. 558–565, 2014. View at Publisher · View at Google Scholar
  • Guusje Collin, Rene S. Kahn, Marcel A. de Reus, Wiepke Cahn, and Martijn P. van den Heuvel, “Impaired Rich Club Connectivity in Unaffected Siblings of Schizophrenia Patients,” Schizophrenia Bulletin, vol. 40, no. 2, pp. 438–448, 2014. View at Publisher · View at Google Scholar
  • Judith M. Ford, Sarah E. Morris, Ralph E. Hoffman, Iris Sommer, Flavie Waters, Simon McCarthy-Jones, Robert J. Thoma, Jessica A. Turner, Sarah K. Keedy, Johanna C. Badcock, and Bruce N. Cuthbert, “Studying Hallucinations Within the NIMH RDoC Framework,” Schizophrenia Bulletin, vol. 40, pp. S295–S304, 2014. View at Publisher · View at Google Scholar
  • Dominic H. Ffytche, and Cynthia G. Wible, “From Tones in Tinnitus to Sensed Social Interaction in Schizophrenia: How Understanding Cortical Organization Can Inform the Study of Hallucinations and Psychosis,” Schizophrenia Bulletin, vol. 40, pp. S305–S316, 2014. View at Publisher · View at Google Scholar
  • Peter Kochunov, and L. Elliot Hong, “Neurodevelopmental and Neurodegenerative Models of Schizophrenia: White Matter at the Center Stage,” Schizophrenia Bulletin, vol. 40, no. 4, pp. 721–728, 2014. View at Publisher · View at Google Scholar
  • Franziska Rausch, Daniela Mier, Sarah Eifler, Christine Esslinger, Claudia Schilling, Frederike Schirmbeck, Susanne Englisch, Andreas Meyer-Lindenberg, Peter Kirsch, and Mathias Zink, “Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia,” Schizophrenia Research, 2014. View at Publisher · View at Google Scholar
  • Jacob Cookey, Denise Bernier, and Philip G. Tibbo, “White matter changes in early phase schizophrenia and cannabis use: An update and systematic review of diffusion tensor imaging studies,” Schizophrenia Research, 2014. View at Publisher · View at Google Scholar
  • Fabian Lamster, Winfried Rief, Tania M. Lincoln, Martin Wiesjahn, and Esther Jung, “Explaining Attitudes and Adherence to Antipsychotic Medication: The Development of a Process Model,” Schizophrenia Research and Treatment, vol. 2014, pp. 1–11, 2014. View at Publisher · View at Google Scholar
  • Alexander M. Rapp, Karin Langohr, Dorothee E. Mutschler, and Barbara Wild, “Irony and Proverb Comprehension in Schizophrenia: Do Female Patients “Dislike” Ironic Remarks?,” Schizophrenia Research and Treatment, vol. 2014, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Natália B. Mota, Raimundo Furtado, Pedro P. C. Maia, Mauro Copelli, and Sidarta Ribeiro, “Graph analysis of dream reports is especially informative about psychosis,” Scientific Reports, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Junho Kim, Jong-Yeon Shin, Jong-Il Kim, Jeong-Sun Seo, Maree J. Webster, Doheon Lee, and Sanghyeon Kim, “Somatic deletions implicated in functional diversity of brain cells of individuals with schizophrenia and unaffected controls,” Scientific Reports, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Andreas Schreiner, Anders Svensson, Robert Wapenaar, Pierre Cherubin, Patricia Princet, Larisa Serazetdinova, and Mathias Zink, “Long-acting injectable risperidone and oral antipsychotics in patients with schizophrenia: results from a prospective, 1-year, non-interventional study (InORS),” The World Journal of Biological Psychiatry, pp. 1–12, 2014. View at Publisher · View at Google Scholar
  • F Fernandez-Enright, J L Andrews, K A Newell, C Pantelis, and X F Huang, “Novel implications of Lingo-1 and its signaling partners in schizophrenia,” Translational Psychiatry, vol. 4, no. 1, pp. e348, 2014. View at Publisher · View at Google Scholar
  • Steve Offord, Jay Lin, Dario Mirski, and Bruce Wong, “Impact of Early Nonadherence to Oral Antipsychotics on Clinical and Economic Outcomes Among Patients with Schizophrenia,” Advances in Therapy, vol. 30, no. 3, pp. 286–297, 2013. View at Publisher · View at Google Scholar
  • Mary V. Seeman, “Loss of Libido in a Woman With Schizophrenia,” American Journal of Psychiatry, vol. 170, no. 5, pp. 471–475, 2013. View at Publisher · View at Google Scholar
  • Brenda Happell, Robert Stanton, Wendy Hoey, and David Scott, “Development, validation and initial outcomes of a questionnaire to investigate the views of nurses working in a mental health setting regarding a cardiometabolic health nursing role,” Archives of Psychiatric Nursing, 2013. View at Publisher · View at Google Scholar
  • Xiaoyi Liu, Yunyao Lai, Xijin Wang, Chuanxi Hao, Lei Chen, Zhenyu Zhou, Xin Yu, and Nan Hong, “Reduced white matter integrity and cognitive deficit in never-medicated chronic schizophrenia: A diffusion tensor study using TBSS,” Behavioural Brain Research, 2013. View at Publisher · View at Google Scholar
  • Deepak M. Kasote, Mahabaleshwar V. Hegde, and Surendra S. Katyare, “Mitochondrial dysfunction in psychiatric and neurological diseases: Cause(s), consequence(s), and implications of antioxidant therapy,” BioFactors, 2013. View at Publisher · View at Google Scholar
  • Holly L. Redpath, Deborah Cooper, and Stephen M. Lawrie, “Imaging Symptoms and Syndromes: Similarities and Differences Between Schizophrenia and Bipolar Disorder,” Biological Psychiatry, vol. 73, no. 6, pp. 495–496, 2013. View at Publisher · View at Google Scholar
  • Michelle K. Jetha, Xin Zheng, Joel O. Goldberg, Sidney J. Segalowitz, and Louis A. Schmidt, “Shyness and Emotional Face Processing in Schizophrenia: An ERP study,” Biological Psychology, 2013. View at Publisher · View at Google Scholar
  • Debra Jeffery, Sarah Clement, Elizabeth Corker, Louise M. Howard, Joanna Murray, and Graham Thornicroft, “Discrimination in relation to parenthood reported by community psychiatric service users in the UK: a framework analysis,” Bmc Psychiatry, vol. 13, 2013. View at Publisher · View at Google Scholar
  • Federica Pinna, Massimo Tusconi, Marta Bosia, Roberto Cavallaro, and Bernardo Carpiniello, “Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders,” Bmc Psychiatry, vol. 13, 2013. View at Publisher · View at Google Scholar
  • E. Varga, M. Simon, T. Tényi, Zs. Schnell, A. Hajnal, G. Orsi, T. Dóczi, S. Komoly, J. Janszky, R. Füredi, E. Hamvas, S. Fekete, and R. Herold, “Irony comprehension and context processing in schizophrenia during remission – A functional MRI study,” Brain and Language, vol. 126, no. 3, pp. 231–242, 2013. View at Publisher · View at Google Scholar
  • Malgorzata Kowalczyk, Aleksander Owczarek, Renata Suchanek, Monika Paul-Samojedny, Anna Fila-Danilow, Paulina Borkowska, Krzysztof Kucia, and Jan Kowalski, “Heat shock protein 70 gene polymorphisms are associated with paranoid schizophrenia in the Polish population,” Cell Stress and Chaperones, 2013. View at Publisher · View at Google Scholar
  • Eoin Killackey, Mario Alyarez-Jimenez, Kelly Allott, Sarah Bendall, and Patrick McGorry, “Community Rehabilitation and Psychosocial Interventions for Psychotic Disorders in Youth,” Child and Adolescent Psychiatric Clinics of North America, vol. 22, no. 4, pp. 745–+, 2013. View at Publisher · View at Google Scholar
  • Patrizia Thoma, Denise Soria Bauser, Christine Norra, Martin Brüne, Georg Juckel, and Boris Suchan, “Do you see what I feel? – Electrophysiological correlates of emotional face and body perception in schizophrenia,” Clinical Neurophysiology, 2013. View at Publisher · View at Google Scholar
  • Ashok Malla, Pierre Chue, Gerald Jordan, Emmanuel Stip, David Koczerginski, Heather Milliken, Anil Joseph, Richard Williams, Beverly Adams, Rahul Manchanda, Kola Oyewumi, and Marc-André Roy, “An Exploratory Open-Label Randomized Trial Comparing Risperidone Long Acting Injectable (RLAI) with Oral Antipsychotic Medication in the Treatment of Early Psychosis,” Clinical Schizophrenia & Related Psychoses, vol. 1, no. -1, pp. 1–26, 2013. View at Publisher · View at Google Scholar
  • Giulio Scigliano, and Gabriele Ronchetti, “Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis,” Cns Drugs, vol. 27, no. 4, pp. 249–257, 2013. View at Publisher · View at Google Scholar
  • Steffen Moritz, and Niels Van Quaquebeke, “Are you sure? Delusion conviction moderates the behavioural and emotional consequences of paranoid ideas,” Cognitive Neuropsychiatry, pp. 1–17, 2013. View at Publisher · View at Google Scholar
  • Robyn Langdon, Megan Still, Michael H. Connors, Philip B. Ward, and Stanley V. Catts, “Jumping to delusions in early psychosis,” Cognitive Neuropsychiatry, pp. 1–16, 2013. View at Publisher · View at Google Scholar
  • Carlo Marchesi, Andrea Affaticati, Alberto Monici, Chiara De Panfilis, Paolo Ossola, and Matteo Tonna, “Predictors of symptomatic remission in patients with first-episode schizophrenia: a 16 years follow-up study,” Comprehensive Psychiatry, 2013. View at Publisher · View at Google Scholar
  • Pierre Thomas, Benjamin Rolland, Olivier Cottencin, Regis Bordet, Julie Deguil, and Renaud Jardri, “Therapeutic Prospects of PPARs in Psychiatric Disorders: A Comprehensive Review,” Current Drug Targets, vol. 14, no. 7, pp. 724–732, 2013. View at Publisher · View at Google Scholar
  • Julia Sacher, Peter Schoenknecht, Karsten Mueller, and Johann Steiner, “Serum S100B Represents a New Biomarker for Mood Disorders,” Current Drug Targets, vol. 14, no. 11, pp. 1237–1248, 2013. View at Publisher · View at Google Scholar
  • Arash Raoufinia, Timothy Peters-Strickland, Ross A. Baker, Anna Eramo, Steven G. Potkin, Robert McQuade, Suresh Mallikaarjun, Patricia Bricmont, William Kasper, and Raymond Sanchez, “Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole,” Current Medical Research And Opinion, vol. 29, no. 10, pp. 1241–1251, 2013. View at Publisher · View at Google Scholar
  • Thomas Becker, and Silke Wiegand-Grefe, “Mental health services for parents affected by mental illness,” Current Opinion in Psychiatry, vol. 26, no. 4, pp. 362–368, 2013. View at Publisher · View at Google Scholar
  • Melissa L. Perreault, Theresa Fan, Brian F. O'Dowd, and Susan R. George, “Enhanced Brain-Derived Neurotrophic Factor Signaling in the Nucleus Accumbens of Juvenile Rats,” Developmental Neuroscience, vol. 35, no. 5, pp. 384–395, 2013. View at Publisher · View at Google Scholar
  • Christopher R. Bowie, Michael Grossman, Maya Gupta, L. Kola Oyewumi, and Philip D. Harvey, “Cognitive remediation in schizophrenia: efficacy and effectiveness in patients with early versus long-term course of illness,” Early Intervention in Psychiatry, 2013. View at Publisher · View at Google Scholar
  • Cali F. Bartholomeusz, Kelly Allott, Eoin Killackey, Ping Liu, Stephen J. Wood, and Andrew Thompson, “Social cognition training as an intervention for improving functional outcome in first-episode psychosis: a feasibility study,” Early Intervention in Psychiatry, vol. 7, no. 4, pp. 421–426, 2013. View at Publisher · View at Google Scholar
  • Guusje Collin, Marcel A. de Reus, Wiepke Cahn, Hilleke E. Hulshoff Pol, René S. Kahn, and Martijn P. van den Heuvel, “Disturbed grey matter coupling in schizophrenia,” European Neuropsychopharmacology, vol. 23, no. 1, pp. 46–54, 2013. View at Publisher · View at Google Scholar
  • Michael C. Davis, William P. Horan, and Stephen R. Marder, “Psychopharmacology of the Negative Symptoms of Schizophrenia: Current Status and Prospects for Progress,” European Neuropsychopharmacology, 2013. View at Publisher · View at Google Scholar
  • Rajesh Dubey, “Controlled-release injectable microemulsions: recent advances and potential opportunities,” Expert Opinion on Drug Delivery, pp. 1–15, 2013. View at Publisher · View at Google Scholar
  • Adrianna Mendrek, “Sex steroid hormones and brain function associated with cognitive and emotional processing in schizophrenia,” Expert Review of Endocrinology & Metabolism, vol. 8, no. 1, pp. 1–3, 2013. View at Publisher · View at Google Scholar
  • Nilesh W. Gaikwad, “Mass spectrometry evidence for formation of estrogen-homocysteine conjugates: Estrogens can regulate homocysteine levels,” Free Radical Biology and Medicine, vol. 65, pp. 1447–1454, 2013. View at Publisher · View at Google Scholar
  • Gursharan Chana, Tammie T. Money, Brian Dean, Andrew Gibbons, Piers Gillett, Chad A. Bousman, and Ian P. Everall, “Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis,” Frontiers In Cellular Neuroscience, vol. 7, 2013. View at Publisher · View at Google Scholar